ADO09 Pramlintide-insulin co-formulation improves time in range for type 1 diabetes
Previously Published on Healio.com – ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter. “ADO09 is a new and innovative co-formulation of two hormones missing in type 1 diabetes: insulin…